Hepatocellular carcinoma diagnosis and treatment

Hepatocellular cancer is the fifth most common cancer, with 600,000 new cases reported each year worldwide. Additionally, exciting changes in the science of HCC in the last four years have turned the practice of diagnosing and treating the disease upside down. In Hepatocellular Carcinoma: Diagnosis...

Full description

Saved in:
Bibliographic Details
Other Authors: Carr, Brian I. (Editor)
Format: Book
Language:English
Published: Totowa Humana 2010
Edition:Second Edition
Series:Current clinical oncology
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000 i 4501
001 wils-431491
005 2020101795424
008 230811t20102010NJU a# #001 deng D
020 # # |a 9781603273732  |q hardback 
020 # # |a 1603273735  |q hardback 
040 # # |a UKM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a WI 735 
090 0 0 |a WI735  |b H529 2010 
245 1 0 |a Hepatocellular carcinoma  |b diagnosis and treatment  |c edited by Brian I. Carr 
250 # # |a Second Edition 
264 # 1 |a Totowa  |b Humana  |c 2010 
264 # 4 |c ©2010 
300 # # |a xvi, 748 pages  |b come color illustrations, maps  |c 25cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
490 1 # |a Current clinical oncology 
504 # # |a Includes bibliographical references and index 
520 # # |a Hepatocellular cancer is the fifth most common cancer, with 600,000 new cases reported each year worldwide. Additionally, exciting changes in the science of HCC in the last four years have turned the practice of diagnosing and treating the disease upside down. In Hepatocellular Carcinoma: Diagnosis and Treatment, Second Edition, the leading experts in the field of HCC thoroughly update and expand upon the critically acclaimed first edition with all the latest developments in the diagnosis and treatment of primary liver cancer. The book details for physicians the diagnostic and therapeutic decision making process for dealing with such problems as incidental tumors in the liver transplant, the role of neo-adjuvant chemotherapy, intra-arterial vs intravenous therapy, the uses of embolization, and the significance of portal vein thrombus. New chapters discuss the introduction into clinical practice of cell cycle growth inhibitors, an expanded knowledge of Genomics and Proteomics, and novel ways of delivering intra-hepatic chemotherapy. This cutting-edge text is a vital resource and must have for today's hepatologists and medical and surgical oncologists 
650 1 2 |a Carcinoma, Hepatocellular  |x therapy 
650 2 2 |a Carcinoma, Hepatocellular  |x diagnosis 
650 2 2 |a Liver Neoplasms 
700 1 # |a Carr, Brian I.  |e editor 
730 0 # |a Hepatocellular cancer 
830 0 # |a Current clinical oncology 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=431491 
964 # # |c BOK  |d MD 
998 # # |a 00250##a006.11||00250##b006.11||00264#1a006.11||00264#1b006.11||00300##a006.11||00300##b006.11||00300##c006.11||00520##a006.11||00520##b006.11||